Drug intelligence / Profile preview

Shenling Guben Immune Granules

Development stage: Preclinical
Administration: Oral

Overview

Shenling Guben Immune Granules (参灵固本免疫颗粒) is a multi-component traditional Chinese medicine preparation designed to enhance immune function and exhibit anti-aging properties. Research suggests its mechanism involves modulating various cellular pathways, including B cell and T cell receptor signaling, and interacting with key proteins such as interleukin-6, tumor necrosis factor, AKT1, VEGFA, STAT3, MAPK1, SRC, EGFR, IL1B, and PTGS2. This preparation is being investigated for its potential therapeutic benefits in conditions like menopausal syndrome, polycystic ovary syndrome, and cancer-related fatigue by improving the body's immunity.

Other names: 参灵固本免疫颗粒

Targets

EGFR (Epidermal growth factor receptor)VEGFA (Vascular endothelial growth factor A)SRC (Proto-oncogene tyrosine-protein kinase Src)MAPK3 (Mitogen-activated protein kinase 1)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TNFA (Tumor necrosis factor alpha (soluble))STAT3 (Signal Transducer and Activator of Transcription 3)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Shenling Guben Immune Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenling Guben Immune Granules.

Explore the full profile